StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd

Bullboard Posts

Comment by Biggaineron Jun 10, 2020 2:53pm

61 Views

Post# 31134851

RE:RE:RelevantStock biggest pumper with no Facts.

At one time, I did own some shares, when it was called GenNews. I don't know why i bought, I knew the technology has been around for years and they had no market attration and no sales, but maybe I thought they might have something there with their Sentinel Principle. Maybe it was howard-Tripp's British accent, and the way he promoted the company and the technology with such assuance in his British voice. I was always a sucker for British accent I guess.

Bullboard Posts

Changing Europe’s dependency on HREE from China